StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$1.00+0.06 (+6.17%)

Close on Nov 17, 2026Market cap $642.47MP/E –Yield –

Earnings

Geron's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$60.10M
+27.3% on a year earlier
EPS, Q3 FY2026
$0.00
Latest guidance
Issued
Nov 4, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Geron's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026before the open$60.10M+27.3%$0.00Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026before the open$57.48M+17.3%-$0.02Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026before the open$48.00M+1.1%-$0.05Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025before the open$47.20M+66.8%–Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025before the open$49.00M+5455.6%-$0.02Release
Q1 FY2025ended Mar 31, 2025May 7, 2025before the open$39.60M+12926.3%-$0.03Release
Q4 FY2024ended Dec 31, 2024Feb 26, 2025before the open$47.50M+206421.7%-$0.04Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open$28.30M+17156.1%-$0.04Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024before the open$882.00K+2941.4%-$0.10Release
Q1 FY2024ended Mar 31, 2024May 2, 2024before the open$304.00K–-$0.09Release
Q4 FY2023ended Dec 31, 2023Feb 28, 2024before the open$23.00K-77.7%-$0.09Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Geron's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
RYTELO net product revenueFY2026$220.00M – $240.00M–NewNov 4, 2026
RYTELO net product revenueFY2026$220.00M – $240.00M$220.00M – $240.00MReaffirmedAug 6, 2026
total operating expensesFY2026$220.00M – $230.00M–NewNov 4, 2026
total operating expensesFY2026$230.00M – $240.00M$230.00M – $240.00MReaffirmedAug 6, 2026

Guidance vs results

The last range Geron gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q4 FY2024Revenue$45.00M – $46.00M$47.50MAbove range

Guidance history

Every forecast Geron put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026total operating expensesFY2026$220.00M – $230.00MNew
Nov 4, 2026RYTELO net product revenueFY2026$220.00M – $240.00MNew
Aug 6, 2026total operating expensesFY2026$230.00M – $240.00MReaffirmed
Aug 6, 2026RYTELO net product revenueFY2026$220.00M – $240.00MReaffirmed
Feb 25, 2026total operating expensesFY2026$230.00M – $240.00MNew
Feb 25, 2026RYTELO net product revenueFY2026$220.00M – $240.00MNew
Nov 5, 2025total operating expensesFY2025$250.00M – $260.00MLowered
Aug 6, 2025total operating expensesFY2025$270.00M – $285.00MNew
May 7, 2025total operating expensesFY2025$270.00M – $285.00MNew
Feb 26, 2025total operating expensesFY2025$270.00M – $285.00MReaffirmed
Jan 13, 2025expected OpEx rangeFY2024$250.00M – $260.00MLowered
Jan 13, 2025expected OpEx rangeFY2025$270.00M – $285.00MNew
Jan 13, 2025estimated net revenuesQ4 FY2024$45.00M – $46.00MNew
Nov 7, 2024total operating expensesFY2024$260.00M – $270.00MLowered
Aug 8, 2024total operating expensesFY2024$270.00M – $280.00MNew
May 2, 2024employeesFY2024250 – 300Raised
May 2, 2024total operating expensesFY2024$270.00M – $280.00MReaffirmed
Feb 28, 2024employeesFY2024270New
Feb 28, 2024total operating expensesFY2024$270.00M – $280.00MNew
Nov 2, 2023employeesFY2023160Raised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Geron filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. Results
  4. Results
  5. Update
  6. Update
  7. Results
  8. Update
  9. Results
  10. Results
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?